Nucleic Acid Services
Nucleic acid therapeutics represent a rapidly growing class of molecular medicines designed to intervene at the genetic level. Rather than targeting downstream proteins like traditional small molecules or monoclonal antibodies, these agents act upstream to induce protein expression, silence disease-causing genes, alter pre-mRNA splicing, or directly block molecular targets.The primary types of nucleic acids currently being developed and utilized for therapeutic purposes fall into three main functional categories: coding RNAs, gene-silencing/modulating oligonucleotides, and structural/DNA-based modalities.
Unlok Development can help you identify the appropriate CDMO for your nucleic acid particularly where specific conjugation or modification may be required. We also have experience in design and synthesis of hybrid nucleic acids that contain both enzymatic and chemically produced components.
